Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
521,4 USD | -4,14% | -4,80% | +10,57% |
15/05 | Transcript : Elevance Health, Inc. - Shareholder/Analyst Call | |
26/04 | HCA verslaat eerstekwartaalwinstramingen door hogere opnames van patiënten | RE |
Omzet 2024 * | 172 mld. 158 mld. | Omzet 2025 * | 182 mld. 168 mld. | Marktkapitalisatie | 121 mld. 112 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 8,04 mld. 7,42 mld. | Nettowinst (verlies) 2025 * | 9,09 mld. 8,38 mld. | EV/omzet 2024 * | 0,81 x |
Nettoschuld 2024 * | 17,19 mld. 15,85 mld. | Nettoschuld 2025 * | 13,67 mld. 12,6 mld. | EV/omzet 2025 * | 0,74 x |
K/w-verhouding 2024 * |
15,1
x | K/w-verhouding 2025 * |
13,2
x | Werknemers | 104.900 |
Dividendrendement 2024 * |
1,2% | Dividendrendement 2025 * |
1,29% | Vrij verhandelbaar | 99,6% |
Recentste transcriptie over Elevance Health, Inc.
1 dag | -4,14% | ||
1 week | -4,80% | ||
Lopende maand | -1,36% | ||
1 maand | -3,39% | ||
3 maanden | +1,42% | ||
6 maanden | +8,92% | ||
Lopend jaar | +10,57% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Gail Boudreaux
CEO | Chief Executive Officer | 63 | 20-11-17 |
Mark Kaye
DFI | Director of Finance/CFO | 45 | 06-09-23 |
Ratnakar Lavu
CTO | Chief Tech/Sci/R&D Officer | 53 | 05/02 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 74 | 01-10-13 | |
Director/Board Member | 55 | 01-11-22 | |
Gail Boudreaux
CEO | Chief Executive Officer | 63 | 20-11-17 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
3.22% | 17 M€ | +7,15% | - | |
2.36% | 1 085 M€ | +8,85% | - | |
2.07% | 8 M€ | +4,90% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
24-05-24 | 521,4 | -4,14% | 1 533 777 |
23-05-24 | 543,9 | -0,70% | 532 736 |
22-05-24 | 547,8 | +0,40% | 766 419 |
21-05-24 | 545,6 | +0,74% | 606 377 |
20-05-24 | 541,6 | -1,11% | 534 706 |
uitgestelde koers Nyse, 24 mei 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+10,57% | 121 mld. | |
-3,48% | 468 mld. | |
+11,07% | 94,49 mld. | |
-23,70% | 42,09 mld. | |
-8,08% | 19,46 mld. | |
-27,38% | 2,57 mld. | |
-16,84% | 1,37 mld. | |
+5,03% | 496 mln. |